Research on GLP-1s, a class of weight-loss drugs that includes Ozempic and semaglutide, is revealing potential neurological benefits. These benefits may include positive effects on brain health and mental health, with some studies suggesting a possible impact on mood, cravings, and mental well-being. The extent and nature of these benefits are still being explored, with ongoing research aiming to clarify the effects of GLP-1s on the brain and mental health.